InsidersTradesSigma
奥翔药业: directors' dealings · France · AMF
SSE:603229FR·AMFMcap 8.2Bn€
Explore the full insider trade history of 奥翔药业, a listed equity based in France. Shares trade on FR FR, under the supervision of AMF. Market capitalisation: €8.2bn. The latest transaction was reported on 21 December 2022 — Sale. Among the most active insiders: 刘兵. All data is free.
9
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
9 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
9.96 €
Income statement
Revenue792.8 M€
Gross profit424.2 M€54% margin
Net income130.6 M€16.5% margin
Balance sheet & cash
Market cap8.24 Bn€
Total debt456.6 M€
Free Cash Flow52.1 M€
Last declaration on 21 December 2022
Declarations9 total
9 of 9 declarations